Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James R. Gavin III currently holds 39,508 shares of AMYLIN PHARMACEUTICALS INC (AMLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James R. Gavin III has been a net seller of AMLN stock. They have purchased $0 and sold $5.3M worth of shares.
James R. Gavin III's most recent insider trade was on Aug 3, 2020, when they sold 3,351 shares at $86.91 per share.
James R. Gavin III serves as Executive at AMYLIN PHARMACEUTICALS INC (AMLN). They have executed 52 insider transactions totaling $5.3M over their tenure at the company.
James R. Gavin III holds the position of Executive at AMYLIN PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
James R. Gavin III has shown a selling trading pattern, with $0 in total purchases and $5.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James R. Gavin III was on Mar 28, 2018, when they sold $1.1M worth of BAX shares. This transaction involved 17,050 shares at $64.51 per share.
James R. Gavin III currently owns 39,508 shares of AMYLIN PHARMACEUTICALS INC (AMLN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James R. Gavin III's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James R. Gavin III has 52 Form 4 filings on record as an insider at AMYLIN PHARMACEUTICALS INC.
Set alerts for James R. Gavin III and 40,000+ other insiders.